FdaApplication

NDA 020789

Back to search

Identifiers

Properties

PropertyValue
applicant_nameADVANZ PHARMA (US) CORP
application_typeNDA
approval_date2000-03-27

Products (3)

ProductActive ingredientStrengthDosage form
ZONEGRANZONISAMIDE100MGCAPSULE;ORAL
ZONEGRANZONISAMIDE25MGCAPSULE;ORAL
ZONEGRANZONISAMIDE50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE;ORAL

3 products